High IL-17 levels in tumor tissues have been associated with tumor drug resistance.270,326 As described above, IL-17 can act either directly on CSCs to promote tumor proliferation, metastasis, and recurrence, or indirectly by altering the composition of the tumor microenvironment, thereby modulating tumor cell growth and leading to their recurrence and drug resistance. This evidence concerns the gene IL17A and neoplasm.